Editorial Board Member
Riham Bokhtia is affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, and has developed a research profile represented in international scholarly indexing systems. The available Scopus record identifies 13 documents, 152 citations, and an h-index of 6, providing quantitative indicators of publication activity and citation visibility. [1]
Abstract
Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy, Zagazig University, Egypt. Her scholarly profile is represented in the Scopus database by 13 indexed documents, 152 citations, and an h-index of 6. The available information places her research within the molecular subject area and provides a basis for describing her academic publication activity, research visibility. [1]
Keywords
Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, with research interests spanning molecular chemistry. Her scholarly profile is represented through Scopus-indexed publications while her Scopus research profile provides indicators of scholarly impact. recognizing research contributions within chemistry and related scientific disciplines.[2]
Introduction
Academic research profiles provide a structured means of evaluating scholarly activity through publication records, citation patterns, and bibliometric indicators. Scopus is a major abstract and citation database used to index scholarly literature and to provide author-level indicators such as document counts, citation counts, and h-index values. [1]
Research Profile
The available bibliometric information identifies a documented research record associated with a Scopus Author profile. The indexed publications demonstrate scholarly activity and citation engagement, reflecting an established publication footprint and research visibility within the academic literature and broader scholarly presence in molecular research.[4]
Research Contributions
Bokhtia’s research profile is situated at the intersection of molecular science and pharmaceutical research. The molecular subject designation provides a broad indication of the scientific domain represented in the supplied academic record. Detailed assessment of individual research contributions should be based on the full-text publications and documented findings associated with each indexed work. [3]
Publications
For formal academic evaluation, the publication record can be reviewed through the researcher’s Scopus profile and, where available, individual publisher records and DOI registrations. These sources allow publication titles, journal information, publication years, authorship, citation metadata, and persistent identifiers to be verified independently. [4]
Research Impact
The reported 152 citations provide an observable indicator of scholarly use or discussion of the indexed documents, while the h-index of 6 indicates that at least six indexed publications have each received at least s ix citations under the relevant database calculation. Bibliometric indicators should, however, be interpreted alongside disciplinary norms. [2]
Award Suitability
On the supplied evidence, her profile demonstrates established scholarly activity through 13 Scopus-indexed documents, 152 citations, and an h-index of 6. Final award assessment should additionally consider the originality, significance, quality, and documented scientific contribution of the underlying publications and any applicable award criteria. [3]
Conclusion
Riham Bokhtia’s academic profile reflects a documented research presence in the molecular and pharmaceutical research context. Her Scopus record reports 13 documents, 152 citations, and an h-index of 6, providing quantitative evidence of publication activity and citation visibility. These indicators support consideration of her scholarly profile within an academic recognition context. [4]
External Links
References
- Elsevier. (n.d.). Scopus author details: Riham Bokhtia, Author ID 57209660751. Scopus.
https://www.scopus.com/pages/authors/57209660751
- ORCID. (n.d.). ORCID record for Riham Bokhtia.
https://orcid.org/0000-0001-5326-7364
- International Research Chemistry Awards. (n.d.).
https://researchchemistry.org
- Bokhtia, R. M., et al. (n.d.). Imidazole–sulfonamide hybrid conjugate: A privilege scaffold with significant therapeutic potential
https://doi.org/10.1016/j.ejmcr.2025.100321